表紙
市場調査レポート

末梢動脈疾患(PAD)/末梢血管疾患(PVD):世界の臨床試験レビュー

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H2, 2013

発行 GlobalData 商品コード 289942
出版日 ページ情報 英文 101 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
末梢動脈疾患(PAD)/末梢血管疾患(PVD):世界の臨床試験レビュー Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H2, 2013
出版日: 2013年10月31日 ページ情報: 英文 101 Pages
概要

当レポートでは、世界の末梢動脈疾患(PAD)/末梢血管疾患(PVD)治療薬の臨床試験(治験)について調査分析し、地域・進捗状況・フェーズ(相)・募集状況別の実施件数や、代表的なスポンサー、開発中の治療薬の情報、臨床試験プロファイルなどを提供して、概略以下の構成でお届けいたします。

目次

イントロダクション

地域別の臨床試験

  • 国別の臨床試験
    • アジア太平洋地域の主要5ヶ国
    • 欧州の主要5ヶ国
    • 北米の主要国
    • 中東・アフリカの主要5ヶ国
    • 中南米の主要国

BRIC諸国の臨床試験

G7諸国の臨床試験

G7諸国の臨床試験:段階別

E7諸国の臨床試験

E7諸国の臨床試験:段階別

フェーズ別の臨床試験

進捗状況

段階別の臨床試験

未完了の臨床試験

一定期間に採用された被験者

有力スポンサー

  • 参加している主要企業

有望な治療薬の比較

臨床試験プロファイル

  • 主要企業の臨床試験の概要
    • Sanofi
    • AstraZeneca PLC
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Utrecht Holdings
    • Foxhollow Technologies, Inc.(休止中)
    • AnGes MG, Inc.
    • Bracco Diagnostics Inc.
    • Bayer AG
    • ActivBiotics Canada, Inc.
  • 主要大学・研究機関・病院の臨床試験の概要
    • National Heart, Lung, and Blood Institute
    • Medical University of Vienna
    • Northwestern University
    • University Hospital, Angers
    • 名古屋大学
    • Duke University
    • University of Virginia
    • The University of Aberdeen
    • Brigham and Women's Hospital
    • Academic Medical Centre

主要な臨床プロファイル(5件)

付録

図表

目次
Product Code: GDHC1813CTIDB

GlobalData's clinical trial report, "Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H2, 2013" provides data on the Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials by Country
    • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
    • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
    • Sanofi
    • Clinical Trial Overview of Sanofi
    • AstraZeneca PLC
    • Clinical Trial Overview of AstraZeneca PLC
    • Pfizer Inc.
    • Clinical Trial Overview of Pfizer Inc.
    • Merck & Co., Inc.
    • Clinical Trial Overview of Merck & Co., Inc.
    • Utrecht Holdings
    • Clinical Trial Overview of Utrecht Holdings
    • Foxhollow Technologies, Inc. (Inactive)
    • Clinical Trial Overview of Foxhollow Technologies, Inc. (Inactive)
    • AnGes MG, Inc.
    • Clinical Trial Overview of AnGes MG, Inc.
    • Bracco Diagnostics Inc.
    • Clinical Trial Overview of Bracco Diagnostics Inc.
    • Bayer AG
    • Clinical Trial Overview of Bayer AG
    • ActivBiotics Canada, Inc.
    • Clinical Trial Overview of ActivBiotics Canada, Inc.
  • Clinical Trial Overview of Top Institutes / Government
    • National Heart, Lung, and Blood Institute
    • Clinical Trial Overview of National Heart, Lung, and Blood Institute
    • Medical University of Vienna
    • Clinical Trial Overview of Medical University of Vienna
    • Northwestern University
    • Clinical Trial Overview of Northwestern University
    • University Hospital, Angers
    • Clinical Trial Overview of University Hospital, Angers
    • Nagoya University
    • Clinical Trial Overview of Nagoya University
    • Duke University
    • Clinical Trial Overview of Duke University
    • University of Virginia
    • Clinical Trial Overview of University of Virginia
    • The University of Aberdeen
    • Clinical Trial Overview of The University of Aberdeen
    • Brigham and Women's Hospital
    • Clinical Trial Overview of Brigham and Women's Hospital
    • Academic Medical Centre
    • Clinical Trial Overview of Academic Medical Centre
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Zone, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, North America, Top Countries, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Central and South America, Top Countries, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, BRIC Countries, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, G7 Countries, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, E7 Countries, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Phase, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Withdrawn Clinical Trials, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Terminated Clinical Trials, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Utrecht Holdings, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Foxhollow Technologies, Inc. (Inactive), 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bracco Diagnostics Inc., 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by ActivBiotics Canada, Inc., 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Angers, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya University, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Aberdeen, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2013*

List of Figures

  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Zone (%), 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, North America, Top Countries (%), 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, BRIC Countries (%), 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, G7 Countries (%), 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, E7 Countries (%), 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Phase (%), 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • GlobalData Methodology
Back to Top